Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 44 of Allarity Therapeutics, Inc.'s SEC filings and found 2 warrant series, 1 convertible, 1 ATM program, 1 equity line, 6 shelf registrations, 3 S-1 registrations and 3 completed offerings on file for ALLR. The latest dilution event on file is a registration statement on Apr 24, 2026. Analysis updated Nov 2, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
RADXRadiopharm Theranostics Limited American Depositary Shares
MRKRMarker Therapeutics, Inc.
NEUPNeuphoria Therapeutics Inc.
BOLTBolt Biotherapeutics, Inc.
NCELNewcelX Ltd. Ordinary Shares
DYAIDyadic International, Inc.
JSPRJasper Therapeutics, Inc.
CTXRCitius Pharmaceuticals, Inc.
ESLAEstrella Immunopharma, Inc.
PLURPluri Inc. Common Stock
BIVIBioVie Inc.
ABOSAcumen Pharmaceuticals, Inc.
ATYRaTyr Pharma, Inc.
HEPAHepion Pharmaceuticals, Inc.
KTTAPasithea Therapeutics Corp.